Mercy Medical Center - Joslin Diabetes Center

Mercy's Joslin Diabetes Center (JDC) provides comprehensive diabetes education and insulin management services for people of all ages. Team members include an endocrinologist, nurse diabetes educators, dietitian diabetes educators, a podiatrist, an exercise specialist, and a mental health counselor. Education is provided in both group and individual visits.

What is it?

Mercy's Joslin Diabetes Center (JDC) provides comprehensive diabetes education and insulin management services for people of all ages. Team members include an endocrinologist, nurse diabetes educators, dietitian diabetes educators, a podiatrist, an exercise specialist, and a mental health counselor. Education is provided in both group and individual visits.

Who is it for?

People with pre-diabetes, gestational diabetes, and type 1 and type 2 diabetes, as well as their families.

Why do they do it?

The goal is to provide diagnosed patients with information about healthy lifestyles, knowledge and skills to perform diabetes self-management tasks, and assistance with goal setting to move the patient to a lifestyle that results in good blood glucose control and prevention of diabetes complications.

Impact

JDC is responsive to the needs of an estimated 14,000 patients with diabetes or pre-diabetes through preventive care, screenings, and educational programs.

Contact: Sr. Susan O'Connor
Vice President, Mission Integration
Telephone: 319-398-6912
E-mail: so'connor@mercycare.org

Related Resources

Letter
Public
AHA letter to Representatives Greg Walden, and Frank Pallone expressing support for The Limited Repeal of the IMD Exclusion for Adult Medicaid Beneficiaries…
Press Releases
Public
Tom Nickels Executive Vice President American Hospital Association
Testimony
Public
AHA expresses strong support for legislation that would allow responsible sharing of patient substance use disorder (SU
Webinar Recordings
Monday, December 15, 2014 On behalf of the American Hospital Association (AHA) Sections for Maternal and Child Health and Psychiatric and
Letter
The undersigned groups thank the Drug Enforcement Administration (DEA) for the opportunity to comment on its proposed rule regarding controlled sub
Letter
We concur with the DEA that setting quotas for the production of opioid medications can be an effective step in “preventing the accumulation of con